Zurueck zur Suche

Reporte zur Charge U029325

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

10Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
NY 2 MA 1 MI 1 PA 1 IN 1 OH 1 NJ 1 NH 1 MD 1

VAERS 2257004

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U029325

schwer
Staat
MA
Alter
4,0
Geschlecht
M
Eingang
28.04.2022
Impfdatum
28.04.2022
Beginn
28.04.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Syncope

Symptomtext

Vasovagal syncope

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2357622

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U029325

mild
Staat
MI
Alter
1,2
Geschlecht
M
Eingang
05.07.2022
Impfdatum
16.06.2022
Beginn
28.06.2022
Tage bis Beginn
12,0
Dosis
1
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Rash

Symptomtext

HPI Hx of eczema on L thigh at last office visit earlier this month. No fevers but mom gave tylenol last night. He had shrimp for dinner last night, but rash first started yesterday AM and has been progressively worsening. He had his MMRV vaccine within the last 2 weeks. Rash started with a few spots on face, then broke out more on face, then onto torso and extremities today Water makes rash worse. He is not itching at him. No difficulty breathing or eating, no swelling in mouth

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
No other illnesses noted
Vorgeschichte
None
Andere Medikamente
None
Allergien
No known drug or food allergies
Vorherige Impfungen
-

VAERS 2216422

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U029325

mild
Staat
PA
Alter
4,0
Geschlecht
M
Eingang
05.04.2022
Impfdatum
08.03.2022
Beginn
09.03.2022
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Erythema Local reaction Pain Skin hyperpigmentation Swelling

Symptomtext

Initial local reaction of redness, swelling pain. However, after local reaction resolved, hyperpigmentation of left upper arm has persisted for 1 month. Hyperpigmentation varies through the day. No swelling, fever, pain, limitation in arm movement.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
Penicillin allergy
Vorherige Impfungen
-

VAERS 2331900

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U029325

gering
Staat
IN
Alter
28,0
Geschlecht
F
Eingang
24.06.2022
Impfdatum
24.06.2022
Beginn
24.06.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product administered to patient of inappropriate age Wrong product administered

Symptomtext

MMRV given instead of MMR to adult

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2297507

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U029325

gering
Staat
OH
Alter
-
Geschlecht
F
Eingang
27.05.2022
Impfdatum
19.04.2022
Beginn
17.05.2022
Tage bis Beginn
28,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Overdose

Symptomtext

No additional AEs reported; On 17MAY2022, the patient was administered a second dose of VARIVAX, along with a dose of PROQUAD; This spontaneous report was received from a nurse concerning a 35 year old female patient. Information regarding the patient's medical history, concurrent conditions and concomitant medications was not reported. On 19-APR-2022, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) for prophylaxis (strength, dose, route of administration, anatomical location, lot number and expiration date were not provided). On 17-MAY-2022, the patient was vaccinated with the second dose of varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 milliliter for prophylaxis (lot number U025205 was determined to be valid for varicella virus vaccine live (oka/merck), expiration date reported and established as 13-AUG-2023) (strength, route of administration and anatomical location were not provided) and measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) for prophylaxis (lot number U029325 was determined to be valid for measles, mumps, rubella and varicella (oka-merck) virus vaccine live, expiration date reported and established as 19-MAR-2023) (strength, route of administration and anatomical location were not provided) (overdose). No adverse event reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2267232

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U029325

gering
Staat
NJ
Alter
-
Geschlecht
U
Eingang
09.05.2022
Impfdatum
13.04.2022
Beginn
13.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect dose administered No adverse event

Symptomtext

no AE; a patient received less than recommended dose of PROQUAD; This spontaneous report was received from medical assistant and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 13-APR-2022, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (lot #U029325 verified as valid and expiration date: 19-MAR-2023, albumin status: rHA) (dose, route of administration, injection site were not provided) for prophylaxis. The patient received less than recommended dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (Incorrect dose administered). No additional adverse events were reported (No adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2245469

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U029325

gering
Staat
NH
Alter
-
Geschlecht
U
Eingang
21.04.2022
Impfdatum
11.04.2022
Beginn
11.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Caller reported PROQUAD administered after temperature excursion. PROQUAD Lot # U029325 3/19/2023 experienced 2 excursions during a 24 hour period. One dose was administered after first excursion but before the second excursion occurred therefore; This spontaneous report was received from a registered nurse referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 11-APR-2022, the patient was vaccinated with an improperly stored of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) 0.5 milliliter, subcutaneously, for prophylaxis (lot # U029325 has been verified to be a valid lot number measles, mumps, rubella and varicella (oka-merck) virus vaccine live, expiration date reported and establish as 19-MAR-2023) (strength and anatomical location were not provided). The temperature of storage and time frame of the excursion were -13.3? Celsius (C) for 1 hour and 19 minutes respectively. If a digital data logger was involved was not reported. If a digital data logger was involved was not reported. The vaccine did not experience a previous temperature excursion.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2241112

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge u029325

gering
Staat
NY
Alter
1,0
Geschlecht
F
Eingang
19.04.2022
Impfdatum
19.04.2022
Beginn
19.04.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Wrong product administered

Symptomtext

patient administered MMRV and varicella instead of MMR and varicella. Provider and parent notified. No further intervention required at this time.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
NA
Vorgeschichte
NA
Andere Medikamente
none
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2225718

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U029325

gering
Staat
NY
Alter
4,0
Geschlecht
F
Eingang
09.04.2022
Impfdatum
31.03.2022
Beginn
31.03.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Angioedema

Symptomtext

After Immunization, patient developed Angioedema on her right periorbital area. Treatment: She was given an injection of Epinephrine 0.15 mL in her Left Thigh and Benadryl 12.5mg/5mL PO at 2:55pm.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Angioedema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Hypothyroidism
Andere Medikamente
Synthroid 25mg daily
Allergien
Avocado Allergy
Vorherige Impfungen
-

VAERS 2225110

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U029325

gering
Staat
MD
Alter
-
Geschlecht
M
Eingang
09.04.2022
Impfdatum
23.03.2022
Beginn
23.03.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administered to patient of inappropriate age Wrong product administered

Symptomtext

HCP reports no further AE's; inadvertent administration of PROQUAD instead of MMR II; inadvertent administration of PROQUAD instead of MMR II; This spontaneous report was received from a nurse and refers to a 17-year-old male patient. The patient's medical history and concurrent conditions were not reported. Concomitant medications included varicella virus vaccine live (oka/merck) (VARIVAX) and multiple other vaccines (unspecified). On 23-MAR-2022, the patient was inadvertently vaccinated with a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA) (PROQUAD) subcutaneous injection, 0.5 milliliter, lot #U029325, expiration date: 19-MAR-2023, reconstituted with sterile diluent administered for prophylaxis (strength, and route of administration were not provided) (product administered to patient of inappropriate age) instead of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (wrong product administered). Vaccines were administered. No further adverse events (AE's) were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
STERILE DILUENT
Allergien
-
Vorherige Impfungen
-